Top Industry Leaders in the Advanced Wound Therapy Devices Market
Latest Advanced wound therapy devices Companies Updates:
Integra LifeSciences: Acquired regenerative medicine company Dermagraft in a $535 million deal, bolstering its portfolio of advanced wound care solutions.
ConvaTec: Purchased negative pressure wound therapy (NPWT) specialist Trilogy Health Partners, strengthening its position in a key market segment.
3M: Received FDA clearance for its Tegaderm™ Advanced Tegaderm Plus Film with Hydrocolloid Border, offering improved exudate absorption and pain management for chronic wounds.
Smith & Nephew: Launched its AQUACEL® EXTRA™ Total Contact Dressing, featuring a new design for advanced healing in cavity wounds.
Bioprinting Solutions: Companies like Aspect Biosystems and Regenovo are developing bioprinted skin grafts and other personalized wound treatment options for faster and more effective healing.
AI-powered Wound Management: Systems like HealtheOS and VitalTracer are utilizing AI to analyze wound images and recommend optimal treatment plans, improving clinical decision-making.
List of Advanced wound therapy devices Key companies in the market:
- Smith & Nephew plc (U.K.)
- Mölnlycke Health Care AB (Sweden)
- B. Braun Melsungen AG (Germany)
- ConvaTec Inc. (U.K.)
- Cardinal Health (U.S.)
- KCI Licensing, Inc. (U.S.)
- Lohmann & Rauscher GmbH & Co. KG (Germany)
- DeRoyal Industries, Inc. (U.S.)